Searched for
SANOFI NEWS
Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...- Stocks in news: Axis Bank, Tech Mahindra, Wipro, LTIMindtree, Angel OneMarkets remained range-bound due to lack of fresh catalysts, with several companies in focus for Q1 results. Tech Mahindra reported a signi...
- Sanofi looking to expand India hub with Rs 3.6k-cr pushThe Hyderabad GCC will support Sanofi's global operations spanning commercial, manufacturing, supply chain research and development (R&D) a...
- Sanofi India decides to put headquarters in Mumbai on the blockSanofi's Indian subsidiary is planning to sell its 150,000 sq ft standalone property in Mumbai's Powai area, which serves as its current he...
- Add Sanofi India, target price Rs 9170: ICICI SecuritiesSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 19074.08 Crore) operating in Pharmaceutic...
- Stocks in news: Angel One, CDSL, Apollo Pipes, Cipla, Aster DM HealthcareEquity indices declined on Tuesday. Angel One, CDSL, Apollo Pipes, Cipla, Aster DM Healthcare among top stocks to track today.
- Hold Sanofi India, target price Rs 9170: ICICI SecuritiesSanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentiv...
- Sanofi plans to split consumer health unit to narrow focusSanofi is reviewing options for the potential split, but said the most likely course would be a “capital markets transaction” to form a sep...
- Buy Sanofi India, target price Rs 6738: ICICI SecuritiesSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12894.50 Crore) operating in Pharmaceutic...
- Hold Sanofi India, target price Rs 6885: ICICI DirectSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13611.10 Crore) operating in Pharmaceutic...
- Buy Sanofi India, target price Rs 8500: Centrum BrokingSanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14647.01 Crore) operating in Pharmaceutic...
- Sanofi launches global health brand, to offer 30 meds on non-profit basisThe treatments will be provided under the new Impact brand, part of Sanofi's global health unit launched last year, which sits outside the ...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- EU Commission sees potential in protein-based COVID-19 vaccinesThe vaccines currently being developed by Novavax and Sanofi/Glaxo-Smith-Kline are examples of protein-based vaccines.
- French fury after Sanofi says US to get COVID-19 vaccine firstThe French multinational's chief executive Paul Hudson said Wednesday that the US would get first dibs because its government was helping t...
- Google's Life Sciences group is making another big move to treat diabetesGoogle Life Sciences entered a partnership with Sanofi, a European pharmaceutical company, to develop technologies to treat diabetes.
- Glenmark inks $325-mn licensing deal with SanofiGlenmark Pharmaceuticals licensed its chronic pain molecule to Sanofi Aventis for an upfront payment of $20 million (approximately Rs 89 cr...
- Sanofi-Aventis settles patent row over cancer drugFrench drugmaker Sanofi-Aventis settled its patent row in the US over colon cancer drug Eloxatin with several generic companies, but made n...
- Pharma cos shares extend gain on BSEShares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
Load More
